Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von J.P. Morgan Securities: Rating und Kursziel JPMorgan analyst Jessica Fye bewertet die Aktie von Vertex…

If youre an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech…

Arguably the three most important words in investing are: I dont know. Acknowledging that you dont know for sure what…

The stock market is divided into sectors, with each group of stocks having commonalities with each other, usually because they…

Some of the best possible returns for investors come by not going after megacaps, but instead pursuing stocks that have…

…

Every investor has heard the phrase "buy low, sell high." Its a simple enough piece of advice thats less simple…

Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster results from…

Warren Buffetts mentor Benjamin Graham once said, "In the short run, the market is a voting machine but in the…

Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist: Truist hat das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von der Scotiabank: Aktuelle Bewertung Scotiabank hat das Kursziel für Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807,…

London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays: Aktuelle Bewertung Die Analysten von Barclays stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

New York (www.aktiencheck.de) - Vertex Pharmaceuticals von J.P. Morgan Securities: Aktuelle Bewertung J.P. Morgan Securities hat das Kursziel für die Aktie von…

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Sanford C. Bernstein & Co: Rating und Kursziel Bernstein hat das Kursziel für Vertex Pharmaceuticals…

Whats going on with CRISPR Therapeutics (NASDAQ: CRSP)? The companys shares have been southbound for the better part of three…

Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this years biotech winners, with the shares climbing 27%…

San Francisco (www.aktiencheck.de) - Rating-Update: Die Analysten von Wells Fargo Advisors stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Santa Claus will soon be on his way delivering presents to kids around the world. But could the jolly gift-giver…

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors…

New York (www.aktiencheck.de) - Rating-Update: Andrew Fein, Analyst H.C. Wainwright & Co., bewertet die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Its that time of year again. Im not referring to buying gifts and preparing holiday meals -- although that may…

CRISPR Therapeutics (NASDAQ: CRSP) isnt a stock thats wanting for reasons to invest. Between the solid launch of its first…

FREEHOLD, N.J., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO),…

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer: Oppenheimer hat die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays: Aktuelle Bewertung Die britische Investmentbank Barclays hat das Kursziel für Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities: Aktuelle Bewertung BofA Securities hat ihr Kursziel für die Aktie von Vertex Pharmaceuticals Inc.…

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Aktuelle Bewertung RBC Capital-Analyst, Brian Abrahams, hat das Kursziel für Vertex Pharmaceuticals Inc.…

Block & Leviton is investigating Vertex Pharmaceuticals (Nasdaq: VRTX) for potential securities fraud. Investors who lost money should contact the…

What do Apple (NASDAQ: AAPL) and Vertex Pharmaceuticals (NASDAQ: VRTX) have in common? At first glance, not much. The former…

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are…

Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum…

St. Louis (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Stifel: 1. Hintergrund der Einschätzung zur Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need…

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals. Three Motley Fool contributors…

Investing in biotech stocks isnt for everyone because the very nature of their business is fraught with risk. As a…

…

Nishant Pant breaks down a bull call spread trade in Vertex Pharmaceuticals.…

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Jefferies & Co: Rating und Kursziel Jefferies hat die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…

I think the stock markets valuation has become frothy. And Im in good company; Warren Buffetts actions show that he…

The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark,…

Growth. Its what most investors want more than anything else from their stocks. Some stocks can deliver more of it…

Things arent getting much better for Pfizer (NYSE: PFE). The company is still suffering from the significant drop in sales…

Its getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems…

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Die amerikanische Investmentbank JPMorgan hat sich über die Aussichten der Pharmabranche im Jahr 2025 geäußert und ist insbesondere für Vertex…

Die amerikanische Investmentbank JPMorgan hat sich über die Aussichten der Pharmabranche im Jahr 2025 geäußert und ist insbesondere für Vertex…

Its been a great couple of years for the stock market. From the end of 2022 through Nov. 29, the…

Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding…

What you do in the present makes a huge difference in how successful youll be in the future. This is…

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. This…